[Recipients adverse reactions: guidance supports]

Area of Science:

• Public Health
• Hematology
• Pharmacovigilance

Background:

• The French haemovigilance network has registered transfusion-adverse effects on the e-fit database since 1994.
• Analysis of these adverse events is crucial for patient safety in blood transfusions.

Purpose of the Study:

• To introduce new guidance documents developed by the French agency for the safety of health products (Afssaps) working groups.
• To standardize the analysis and evaluation of transfusion-related adverse reactions.

Main Methods:

• Development of guidance supports by Afssaps working groups, each focusing on a specific blood transfusion side effect.
• Each support includes five key sections: pathophysiological mechanisms, diagnostic criteria, management recommendations, etiologic investigations, and e-fit notification rules.

Main Results:

• Publication of guidance sheets on various transfusion side effects including transfusion-related acute lung injury, bacterial infection, febrile reactions, allergic reactions, circulatory overload, hypotensive reactions, alloimmunization, erythrocyte incompatibility, and hemosiderosis.
• These supports provide guidelines for better analysis, diagnosis, severity assessment, and accountability of adverse reactions.

Conclusions:

• The new guidance documents enhance the analysis and evaluation of adverse reactions in blood transfusion recipients.
• These standardized approaches can potentially foster further research within European and international haemovigilance networks.